Total Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Sell
868
-127
-13% -$27.3K 0.02% 81
2026
Q1
$216K Buy
995
+48
+5% +$10.6K 0.03% 77
2025
Q4
$216K Sell
947
-43
-4% -$9.79K 0.03% 76
2025
Q3
$229K Sell
990
-18
-2% -$3.67K 0.03% 67
2025
Q2
$187K Buy
+1,008
New +$187K 0.03% 80

Other funds holding ABBV

Total Investment Management's ABBV Position: Q2 2026 in Review

Total Investment Management reduced its AbbVie (ABBV) stake by 13% in Q2 2026, selling an estimated $27.3K and leaving 868 shares worth $218K. The position accounts for 0.02% of the portfolio, ranked #81.

Total Investment Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. The position peaked at $229K in Q3 2025. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Total Investment Management held 868 shares of AbbVie worth $218K as of Q2 2026.
  • Total Investment Management sold 127 AbbVie shares in Q2 2026, an estimated $27.3K.
  • AbbVie made up 0.02% of Total Investment Management's portfolio in Q2 2026, its #81 holding.
  • Total Investment Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • Total Investment Management's AbbVie position peaked at $229K in Q3 2025.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Total Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.